Lifestyle of patients with chronic diseases in the communities in Baoshan District of Shanghai during COVID-19 period in 2020
Journal Title: Shanghai Journal of Preventive Medicine - Year 2022, Vol 34, Issue 10
Abstract
ObjectiveTo explore the impact of COVID-19 epidemic on the lifestyles of patients with chronic diseases and to help better chronic disease prevention and control during the epidemic.MethodsThe patients with hypertension and type 2 diabetes who were still under management in Baoshan Districtï¼ Shanghai at the end of September 2019 were selected for the investigation through telephone follow-up from March 1 to April 30 in 2020. 960 participants were selected using a stratified random sampling method. Those who did not complete the investigation for any reasons were excluded. A total of 613 people were effectively investigated. We compared and analyzed the lifestyles of patients with chronic diseases during 2020 ï¼COVID-19ï¼ with those in 2019.ResultsDuring the epidemicï¼ the proportion of people who had regular physical exercise ï¼P<0.05ï¼and transportation activitiesï¼P<0.05ï¼ was lower than that before the epidemic. The proportion of people with lightï¼ moderate and heavy activity intensityï¼P<0.05ï¼ was lower than before the epidemicï¼ and the difference was statistically significant. The time spent on sitting or leaning was more than that before the epidemic ï¼P<0.05ï¼. As for the condition of complying with the doctorâs adviceï¼ no significant difference was found in different age and chronic disease groups. There was a statistically significant difference in total food intake ï¼Ï2=7.994ï¼P<0.05ï¼ and staple foods ï¼Ï2=6.677ï¼P<0.05ï¼ between patients with or without hypertension. There was a statistically significant difference in total food intakeï¼Ï2=10.694ï¼P<0.05ï¼ and staple food intake ï¼Ï2=9.523ï¼P<0.05ï¼ between those with or without diabetes mellitus ï¼P<0.05ï¼. Patients with chronic diseases during the epidemic could not know about latest values of measurement index and had emotional problems such as restlessnessï¼ nervousness and irritability.ConclusionPatients with chronic diseases changes their lifestyles during the epidemicï¼ and their exercise and travel conditions decrease during the COVID-19 lockdown period. Most patients have different levels of emotional problems such as restlessness and nervousness. It is recommended to increase the intensity and frequency of physical activity and promote mental health to better prevent and control the occurrence of chronic diseases.
Authors and Affiliations
WU Cui,DING Liyan,CHEN Qiuyan,LI Yanyun,JIANG Liying,
Effect of paliperidone palmitate treatment on disease family burden and rehabilitation effect in community schizophrenic patients
ObjectiveTo explore the effect of paliperidone palmitate treatment on schizophrenic patients in the community.Methods446 schizophrenic patients who used paliperidone palmitate injection were selected in Shanghai. Before...
Influence of family smoking on children’s exposure to second-hand smoke in rural Taizhou City
<b>Objective:To analyze the household smoking behavior of smokers in rural Taizhou City of Zhejiang Province, and to provide the basis for the intervention measures to reduce children's second-hand smoke (SHS) exposur...
Hospitalization costs of road traffic injury in Shanghai,2017‒2020
Objective To assess the direct economic burden and influencing factors of road traffic injuries in Shanghai, providing a basis for future prevention of road traffic injuries.Methods Information of inpatient cases caused...
Identification and complete genome sequencing of human adenovirus type 55 isolated from a patient with acute hemorrhagic conjunctivitis
ObjectiveTo determine the genomic characteristics of a subgenus B human adenovirus strain isolated in Shanghai in 2021.MethodsAn adenovirus type 55 strain was isolated and identified from a patient with acute hemorrhagic...
Relationship between plasma SP-A expression level and disease stage in silicosis patients
Objective To investigate the relationship between plasma surfactant protein⁃A (SP⁃A) expression level and silicosis progression, and to provide early evidence for exploring whether SP⁃A can be used as a biomarker for...